David Zaccardelli, President and CEO at Verona Pharma plc (VRNA), sold 766,400 shares at $9.33 ($7.1M) on 2025-05-29, disclosed to the SEC on 2025-05-29.
Scheduled sale ($7.1M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.53 | 33,600 | $320K | 4.5% |
| 2 | $9.30 | 157,704 | $1.5M | 20.5% |
| 3 | $9.30 | 157,704 | $1.5M | 20.5% |
| 4 | $9.33 | 208,696 | $1.9M | 27.2% |
| 5 | $9.33 | 208,696 | $1.9M | 27.2% |
| Total | $9.33 avg | 766,400 |
| $7.1M |
| 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $7.0M | — | Filing → |
| VRNA | SELL | 2025-05-01 | $1.6M | — | Filing → |
| VRNA | SELL | 2024-12-06 | $7.6M | — | Filing → |